Ingevity (NGVT) EBT (2015 - 2026)

Ingevity (NGVT) has 12 years of EBT data on file, last reported at $30.2 million in Q1 2026.

• EBT for Q1 2026 came in at $30.2 million, down 19.68% year-over-year; the trailing twelve-month figure through Mar 2026 was -$155.7 million (up 28.87% YoY), and the FY2025 annual result was -$142.1 million, down 1.14% from the prior year.
• EBT improved to $30.2 million in Q1 2026 per NGVT's latest filing, from -$105.4 million in the prior quarter.
• Over five years, EBT peaked at $95.8 million in Q3 2022 and troughed at -$334.6 million in Q2 2024.
• A 5-year average of -$2.8 million and a median of $32.1 million in 2023 frame the typical range for EBT.
• The sharpest annual moves came in 2022 and 2024: EBT jumped 1164.44% in 2022, then plunged 801.47% in 2024.
• A 5-year view of EBT shows it stood at $19.7 million in 2022, then tumbled by 170.56% to -$13.9 million in 2023, then soared by 273.38% to $24.1 million in 2024, then plunged by 537.34% to -$105.4 million in 2025, then surged by 128.65% to $30.2 million in 2026.
• Business Quant data shows NGVT's EBT at $30.2 million in Q1 2026, -$105.4 million in Q4 2025, and $62.2 million in Q3 2025.